Showing results (891-900 of 992) with videos related to

Sort By:
Pageof 100
Therapeutic Advances in Respiratory Disease|October 21, 2020
Effect of once-daily fluticasone furoate/vilanterol versus vilanterol alone on bone mineral density in patients with COPD: a randomized, controlled trialFrancois Maltais, Isabelle Schenkenberger, Pascal L M L Wielders, et al.
Therapeutic Advances in Respiratory Disease|October 22, 2020
Improving home oxygen therapy in patients with interstitial lung diseases: application of a noninvasive ventilation deviceSandra Cuerpo, Maria Palomo, Fernanda Hernández-González, et al.
Therapeutic Advances in Respiratory Disease|October 14, 2020
Use of monoclonal antibodies for allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis: literature reviewIsabel C Eraso, Saveria Sangiovanni, Eliana I Morales, et al.
Therapeutic Advances in Respiratory Disease|October 19, 2020
Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patientsHaoshen Feng, Yabin Zhao, Zhenhua Li, et al.
Therapeutic Advances in Respiratory Disease|October 19, 2020
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational studyGiada Procopio, Anna Cancelliere, Enrico Maria Trecarichi, et al.
Therapeutic Advances in Respiratory Disease|October 26, 2020
Current situation of asthma-COPD overlap in Chinese patients older than 40 years with airflow limitation: a multicenter, cross-sectional, non-interventional studyJian Kang, Jinping Zheng, Baiqiang Cai, et al.
Therapeutic Advances in Respiratory Disease|October 16, 2020
Bronchiectasis and increased mortality in patients with corticosteroid-dependent severe asthma: a nationwide population studyHayoung Choi, Hyun Lee, Jiin Ryu, et al.
Therapeutic Advances in Respiratory Disease|December 7, 2019
What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscapeFederico Lavorini, Christer Janson, Fulvio Braido, et al.
Therapeutic Advances in Respiratory Disease|November 10, 2020
Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trialClaus F Vogelmeier, Edward M Kerwin, Leif H Bjermer, et al.
Therapeutic Advances in Respiratory Disease|November 3, 2020
Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, ChinaXingsheng Hu, Chunhong Hu, Yong Yang, et al.
Pageof 100